These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 26943923
1. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI. Brunelli MJ, Atallah ÁN, da Silva EM. Cochrane Database Syst Rev; 2016 Mar 04; 3():CD009806. PubMed ID: 26943923 [Abstract] [Full Text] [Related]
2. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI. Brunelli MJ, Atallah ÁN, da Silva EM. Cochrane Database Syst Rev; 2021 Sep 17; 9(9):CD009806. PubMed ID: 34533215 [Abstract] [Full Text] [Related]
3. Enzyme replacement therapy outcomes across the disease spectrum: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program. Harmatz PR, Lampe C, Parini R, Sharma R, Teles EL, Johnson J, Sivam D, Sisic Z. J Inherit Metab Dis; 2019 May 17; 42(3):519-526. PubMed ID: 30834539 [Abstract] [Full Text] [Related]
4. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). da Silva EM, Strufaldi MW, Andriolo RB, Silva LA. Cochrane Database Syst Rev; 2014 Jan 08; (1):CD008185. PubMed ID: 24399699 [Abstract] [Full Text] [Related]
10. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I. Jameson E, Jones S, Remmington T. Cochrane Database Syst Rev; 2016 Apr 01; 4():CD009354. PubMed ID: 27033167 [Abstract] [Full Text] [Related]
11. Enzyme replacement therapy initiated in adulthood: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program. Lampe C, Harmatz PR, Parini R, Sharma R, Teles EL, Johnson J, Sivam D, Sisic Z. Mol Genet Metab; 2019 Aug 01; 127(4):355-360. PubMed ID: 31324526 [Abstract] [Full Text] [Related]
13. Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey Study. Giugliani R, Lampe C, Guffon N, Ketteridge D, Leão-Teles E, Wraith JE, Jones SA, Piscia-Nichols C, Lin P, Quartel A, Harmatz P. Am J Med Genet A; 2014 Aug 01; 164A(8):1953-64. PubMed ID: 24764221 [Abstract] [Full Text] [Related]
14. Clinical effectiveness of enzyme replacement therapy with galsulfase in mucopolysaccharidosis type VI treatment: Systematic review. Gomes DF, Gallo LG, Leite BF, Silva RB, da Silva EN. J Inherit Metab Dis; 2019 Jan 01; 42(1):66-76. PubMed ID: 30740728 [Abstract] [Full Text] [Related]